These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34900602)

  • 1. Hypertension and COVID-19: Updates from the era of vaccines and variants.
    Swamy S; Koch CA; Hannah-Shmouni F; Schiffrin EL; Klubo-Gwiezdzinska J; Gubbi S
    J Clin Transl Endocrinol; 2022 Mar; 27():100285. PubMed ID: 34900602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19.
    Kocayigit I; Kocayigit H; Yaylaci S; Can Y; Erdem AF; Karabay O
    Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):71-76. PubMed ID: 32965360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
    Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
    Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hypertension in patients with COVID-19: Implication of angiotensin-converting enzyme 2.
    Jia GH; Sowers JR
    Cardiol Plus; 2021 Oct; 6(4):210-217. PubMed ID: 35368973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient Omission of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With Morbidity and Mortality in Coronavirus Disease 2019.
    Oddy C; Allington J; McCaul J; Keeling P; Senn D; Soni N; Morrison H; Mawella R; Samuel T; Dixon J
    Clin Ther; 2021 Apr; 43(4):e97-e110. PubMed ID: 33712270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
    Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
    Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19.
    Shibata S; Arima H; Asayama K; Hoshide S; Ichihara A; Ishimitsu T; Kario K; Kishi T; Mogi M; Nishiyama A; Ohishi M; Ohkubo T; Tamura K; Tanaka M; Yamamoto E; Yamamoto K; Itoh H
    Hypertens Res; 2020 Oct; 43(10):1028-1046. PubMed ID: 32737423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.
    Dworakowska D; Grossman AB
    J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and COVID-19: Current Evidence and Perspectives.
    Gallo G; Calvez V; Savoia C
    High Blood Press Cardiovasc Prev; 2022 Mar; 29(2):115-123. PubMed ID: 35184271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
    Kreutz R; Algharably EAE; Azizi M; Dobrowolski P; Guzik T; Januszewicz A; Persu A; Prejbisz A; Riemer TG; Wang JG; Burnier M
    Cardiovasc Res; 2020 Aug; 116(10):1688-1699. PubMed ID: 32293003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
    Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
    Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of renin-angiotensin-aldosterone system inhibition with Covid-19 hospitalization and all-cause mortality in the UK biobank.
    Safizadeh F; Nguyen TNM; Brenner H; Schöttker B
    Br J Clin Pharmacol; 2022 Jun; 88(6):2830-2842. PubMed ID: 34935181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study.
    Hakeam HA; Alsemari M; Duhailib ZA; Ghonem L; Alharbi SA; Almutairy E; Sheraim NMB; Alsalhi M; Alhijji A; AlQahtani S; Khalid M; Barry M
    J Cardiovasc Pharmacol Ther; 2021 May; 26(3):244-252. PubMed ID: 33231487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants.
    Noor R; Shareen S; Billah M
    Bull Natl Res Cent; 2022; 46(1):96. PubMed ID: 35431535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System.
    An J; Wei R; Zhou H; Luong TQ; Gould MK; Mefford MT; Harrison TN; Creekmur B; Lee MS; Sim JJ; Brettler JW; Martin JP; Ong-Su AL; Reynolds K
    J Am Heart Assoc; 2021 Feb; 10(3):e019669. PubMed ID: 33307964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and RAAS inhibitors: is there a final conclusion?
    Talebi-Taher M; Najafi MH; Behzad S
    Iran J Microbiol; 2021 Dec; 13(6):728-736. PubMed ID: 35222849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension.
    Lee J; Jo SJ; Cho Y; Lee JH; Oh IY; Park JJ; Cho YS; Choi DJ
    Korean J Intern Med; 2021 Mar; 36(Suppl 1):S123-S131. PubMed ID: 32872731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.